Cross-linking was performed as described

previously. Cells were incubated for 72 h at 37°C and 5% CO2 and pulsed with radioactive [3H]-thymidine for the last 18 h to assess proliferation. The BIACore 2000, sensor chip CM5, surfactant P-20, HBS-EP [10 mM HEPES, 0·15 M NaCl, 3·4 mM ethylendiamine tetraacetic acid (EDTA), 0·005% P-20, pH 7·4], amine coupling kit and 10 mM acetate pH 4·5 were from BIACore, Inc. (Piscataway, NJ, USA). Immobilization of antibodies to the sensor chip surface was performed according to the Target Selective Inhibitor Library manufacturer’s instructions, using a continuous flow of 10 mM HEPES, 0·15 M NaCl, 3·4 mM EDTA and 0·005% P-20, pH 7·4 (HBS-EP buffer). Briefly, carboxyl groups on the sensor chip surfaces were activated by injecting 60 µl of a mixture containing 0·2 M N-ethyl-N′ (dimethylaminopropyl)carbodiimide (EDC) and 0·05 M N-hydroxysuccinimide (NHS). Specific surfaces were obtained by injecting antibody diluted in 10 mM acetate, pH 4·5 at a concentration of 30 µg/ml. Excess reactive groups on the surfaces were deactivated

Selleckchem Trichostatin A by injecting 60 µl of 1 M ethanolamine. Final immobilized levels were ∼9000–12 000 resonance units (RU) for the antibodies. A blank, mock-coupled reference surface was also prepared on the sensor chip. To perform a competition binding analysis of the anti-mBTLA mAbs by BIACore, each antibody was immobilized to a different flow cell of a CM5 sensor chip. Murine BTLA-mFc was captured on the antibody surfaces and then either the immobilized antibody or a different antibody was injected over the captured mBTLA-mFc. DO11.10 splenocytes, 20 × 106, were adoptively transferred into BALB/c recipients. The next day mice were treated intraperitoneally with 15 mg/kg 4��8C of anti-BTLA reagent or control reagent. Three h after protein treatment animals were administered 10 µg of biotin-labelled rat

anti-mIL-2 (clone JES6-5 H4) to capture secreted IL-2 as described previously. Mice were then injected in the footpad with 100 µg of OVA protein to activate the monoclonal population of transferred DO11.10 T cells. The mice were rested for 18 h before exsanguination and then serum IL-2 was detected using an enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA). Studies that benchmarked the effect of CTLA4-Fc in this model were performed in a similar manner. Figure 1 shows the effect of anti-BTLA reagents on the anti-CD3ε-induced proliferation of murine spleen-derived T cells in vitro. We have shown previously that the mHVEM-mFc ligand and all the putative anti-BTLA mAb-stained T and B cells by fluorescence activated cell sorter analysis (FACS) and that the staining could be reversed specifically with soluble mBTLA-mFc (data not shown).